Pettersen, Emily
Sassu, Paolo
Reinholdt, Carina
Dahm, Peter
Rolfson, Ola
Björkman, Anders
Innocenti, Marco
Pedrini, Francesca Alice
Breyer, Juan Manuel
Roche, Aidan
Hart, Andrew
Harrington, Lorraine
Ladak, Adil
Power, Hollie
Hebert, Jacqueline
Ortiz-Catalan, Max http://orcid.org/0000-0002-6084-3865
Funding for this research was provided by:
Stiftelsen Promobilia (21500)
IngaBritt och Arne Lundbergs Forskningsstiftelse (2020-0)
Vetenskapsrådet (2020-04817)
Chalmers University of Technology
Article History
Received: 9 February 2022
Accepted: 31 March 2023
First Online: 2 May 2023
Change Date: 9 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13063-023-07626-0
Declarations
:
: This clinical trial was approved by the Swedish Ethics Review Authority, Etikprövningsmyndigheten, on 30 June 2021 with the application number 2021–02346. Written, informed consent to participate will be obtained from all participants. Participants in this trial are insured by government insurances in each country: Sweden, Italy, Canada, Chile, Australia, UK, and USA. Important protocol modifications will be notified to the ethical committee.
: Not applicable.
: The authors declare that they have no competing interests.